Literature DB >> 8549385

Sparfloxacin, a new generation fluoroquinolone against S. pneumoniae respiratory infections.

Y Niki1, S Tamada, M Nakabayashi, R Soejima.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8549385     DOI： 10.2165/00003495-199500492-00121

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  3 in total

1.  In vitro and in vivo activities of sparfloxacin against Mycoplasma pneumoniae.

Authors:  M Kaku; K Ishida; K Irifune; R Mizukane; H Takemura; R Yoshida; H Tanaka; T Usui; K Tomono; N Suyama
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

2.  In vivo efficacy of a new fluoroquinolone, sparfloxacin, against penicillin-susceptible and -resistant and multiresistant strains of Streptococcus pneumoniae in a mouse model of pneumonia.

Authors:  E Azoulay-Dupuis; E Vallee; B Veber; J P Bedos; J Bauchet; J J Pocidalo
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

3.  Antimicrobial activity of DV-7751a, a new fluoroquinolone.

Authors:  M Tanaka; K Hoshino; H Ishida; K Sato; I Hayakawa; Y Osada
Journal:  Antimicrob Agents Chemother       Date:  1993-10       Impact factor: 5.191
  3 in total
  1 in total

Review 1.  Sparfloxacin. A review of its antibacterial activity, pharmacokinetic properties, clinical efficacy and tolerability in lower respiratory tract infections.

Authors:  K L Goa; H M Bryson; A Markham
Journal:  Drugs       Date:  1997-04       Impact factor: 9.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.